IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care (PRISM-PC)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition |
|---|
| Dementia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Perceptions Regarding Investigational Screening for Memory Problems in Primary Care: The PRISM-PC Study |
- Primary care patients' perceptions of the risks and benefits of early identification of dementia [ Time Frame: Measurement will continue through the duration of the study ]
- Evaluation of the association between primary care patients' acceptance for early identification of dementia and their perceptions of the risks and benefits of such identification after adjusting for potential confounders such as demographics [ Time Frame: Measurement will continue through the duration of the study ]
| Enrollment: | 954 |
| Study Start Date: | February 2008 |
| Study Completion Date: | May 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
The Health Belief Model was used to explore the public's acceptance or enthusiasm for early recognition of dementia. Based on this model, prior research and clinical experiences, and a systematic literature review, the PRISM-PC instrument was developed. The PRISM-PC items seek to capture both the patient's acceptance of dementia screening and the patient's perception of potential harms and benefits of such screening. The instrument includes questions regarding screening by performance-based questionnaires, blood tests, or brain imaging.
The PRISM-PC instrument includes 50 items that are organized into 8 sets of questions that cover the following areas:
A) Prior experience with AD (5 items) B) Acceptance of screening for AD (6 items) C) Acceptance of screening for other conditions (2 items) D) Benefits of screening for AD (9 items) E) Stigma of screening for AD (10 items) F) Impact of screening for AD on independence (6 items) G) Suffering of screening for AD (4 items) H) Demographics (7 items) Excluding section A and H (prior experience with AD and demographics), each item of the six other sections is rated on a 5-point Likert scale (strongly agree, agree, don't know, disagree, and strongly disagree).
Based on the previous PRISM-PC pilot study (a survey response rate of 80%) and the Dementia screening and diagnosis study (screening acceptance rate of 90%, positive dementia screening rate of 20% among participants aged 70 and older, and dementia diagnostic acceptance rate of 50%), a total of 1,500 volunteers will be approached. A random selection of 200 participants will be re-administered the questionnaire within one week to test the short-term temporal stability of their responses (test-retest).
Eligibility| Ages Eligible for Study: | 65 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Aged 65 and older
- At least one office visit to their primary care physician within the last year
- No chart-based diagnosis of dementia or memory problem
- Willing to sign a consent form to participate in the study
Exclusion Criteria:
- Does not speak English
- Too hearing-impaired to hear the informed consent statement or the survey
- Severe mental illness based on the patient's electronic medical charts
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00759252
| United States, Indiana | |
| Indiana University Medical Group | |
| Indianapolis, Indiana, United States, 46202 | |
| Principal Investigator: | Malaz Boustani, MD, MPH | Regenstrief Institute, Center for Aging Research |
More Information
Publications:
| Responsible Party: | Malaz Boustani, MD, MPH, Regenstrief Institute, IU Center for Aging Research Scientist, Indiana University |
| ClinicalTrials.gov Identifier: | NCT00759252 History of Changes |
| Other Study ID Numbers: |
IA0141 R01AG029884 ( U.S. NIH Grant/Contract ) 5R01AG029884-02 ( U.S. NIH Grant/Contract ) |
| Study First Received: | September 24, 2008 |
| Last Updated: | August 27, 2015 |
Keywords provided by Malaz Boustani, MD, MPH, Indiana University:
|
diagnosis of dementia perceptions of risk dementia screening |
Additional relevant MeSH terms:
|
Dementia Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on September 19, 2017